Asia-Pacific specialist CRO Novotech has partnered with the Asian Eye Institute, Inc (AEI), a private eye centre in the ...
Glenmark Pharma’s subsidiary Glenmark Specialty has entered into an exclusive licensing agreement with Australia's...
A problem first posed in a UNSW lecture has driven a current Medicine student to design a pioneering artificial intellig...
An initiative to grow Western Australia’s life sciences and innovation sector and boost local research capability ...
Israeli biotechnology company Kadimastem has announced the approval of the Australian Government and the Israel Innovati...
eHealth Queensland and HIMSS Asia Pacific have signed an agreement for eHealth Queensland to assist with the facilitatio...
Singapore- When it was first discovered in 1976, the cytokine interleukin-2 (IL-2) was characterized as a soluble factor...
According to Australia’s leading news portal ABC news, the country’s largest online doctor appointment servi...
HealthMatch, an Australian start-up aiming to become the go-to platform linking sick patients with clinical trials of po...
Medicines Development for Global Health (MDGH) and the World Health Organisation Special Programme for Research and Trai...
UniQuest, The University of Queensland’s commercialization company, is leading Australia and competing global...
A Melbourne-based life science research and development company has invested more than £3 million in Wales. The m...
Indee Labs has announced that it has received $2.6 million in venture financing extending its seed-stage funding to more...
The Turnbull Government is launching a national awareness campaign to get to get more Australians into ground-breaking c...
Asthma is one of the most common childhood diseases and impacts children’s quality of life, leaving them more susc...
After recommendations by an expert group led by the chief scientist, Alan Finkel, the federal government in Australia re...
Researchers, doctors and patients have teamed with Lung Foundation Australia during this week’s Pneumonia Awa...
Australian biopharmaceutical company NeuClone has announced positive preclinical results of its biosimilar to Johnson &a...
